Junran Zhang
Impact in
- Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment
- Oncology top 2%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
- Oncology 26
- PARP inhibition in cancer therapy 13
- Cancer-related Molecular Pathways 7
-
- DNA Repair Mechanisms 31
- CRISPR and Genetic Engineering 12
- Epigenetics and DNA Methylation 8
- Ubiquitin and proteasome pathways 6
- Co-authors
- Simon N. Powell (9 shared papers)Zhihui Feng (10 shared papers)Zhaojun Qiu (8 shared papers)Chunhong Yan (15 shared papers)Nancy L. Oleinick (2 shared papers)Han‐Fei Ding (5 shared papers)Hongbo Wang (3 shared papers)Mengqi Guo (3 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Molecular Cancer Therapeutics (4 papers)Cancer Research (4 papers)Molecular and Cellular Biology (3 papers)Cell Death and Differentiation (2 papers)
- Partner nations
- United StatesChinaGeorgia
In The Last Decade
Junran Zhang
70 papers receiving 4.2k citations
Junran Zhang's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 868
- Oncology 1.2k
- Molecular Biology 2.8k
- Pulmonary and Respiratory Medicine 689
- Aging 30
Countries citing papers authored by Junran Zhang
This map shows the geographic impact of Junran Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junran Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junran Zhang more than expected).
Fields of papers citing papers by Junran Zhang
This network shows the impact of papers produced by Junran Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junran Zhang. The network helps show where Junran Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Junran Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ATF3 promotes erastin-induced ferroptosis by suppressing system Xc– Hit paper breakdown → | 2019 | 671 |
| 2 | 2005 | 315 | |
| 3 | 2017 | 273 | |
| 4 | 2003 | 269 | |
| 5 | 2005 | 169 | |
| 6 | 2010 | 134 | |
| 7 | 2010 | 122 | |
| 8 | 2006 | 117 | |
| 9 | 2011 | 113 | |
| 10 | 2019 | 113 | |
| 11 | 2005 | 100 | |
| 12 | 2007 | 94 | |
| 13 | 2006 | 89 | |
| 14 | 2010 | 88 | |
| 15 | 2016 | 81 | |
| 16 | 2010 | 80 | |
| 17 | 2015 | 75 | |
| 18 | 2021 | 75 | |
| 19 | 2006 | 70 | |
| 20 | 2013 | 69 |
About Junran Zhang
Junran Zhang is a scholar working on Oncology, Molecular Biology, Cancer Research, Genetics and Cell Biology, having authored 72 papers that have together received 4.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (31 papers), PARP inhibition in cancer therapy (13 papers), CRISPR and Genetic Engineering (12 papers), Epigenetics and DNA Methylation (8 papers), Cancer-related Molecular Pathways (7 papers), Ubiquitin and proteasome pathways (6 papers), BRCA gene mutations in cancer (5 papers) and Carcinogens and Genotoxicity Assessment (4 papers). The work is most often cited by research in Cancer Research (868 citations), Oncology (1.2k citations), Molecular Biology (2.8k citations), Pulmonary and Respiratory Medicine (689 citations) and Aging (30 citations). Junran Zhang has collaborated with scholars based in United States, China and Georgia. Frequent co-authors include Simon N. Powell, Zhihui Feng, Zhaojun Qiu, Chunhong Yan, Nancy L. Oleinick, Han‐Fei Ding, Hongbo Wang, Mengqi Guo, Tingting Du and Xiaoguang Chen. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cancer Therapeutics, Cancer Research, Molecular and Cellular Biology and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.